A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Amgen
ALX Oncology Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Bayer
NiKang Therapeutics, Inc.
Aktis Oncology, Inc.
Novartis
Kumquat Biosciences Inc.
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Seagen Inc.
Boehringer Ingelheim
Seagen Inc.
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Compass Therapeutics
Pliant Therapeutics, Inc.
Pfizer
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Compass Therapeutics
BioNTech SE
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Bristol-Myers Squibb
Eli Lilly and Company
Pheon Therapeutics
AstraZeneca
Pfizer
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Kivu Bioscience Inc.
Instil Bio
M.D. Anderson Cancer Center
AstraZeneca
BeOne Medicines
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Exelixis
BeOne Medicines
Astellas Pharma Inc
Kestrel Therapeutics, Inc.
Amgen
Institut Claudius Regaud